Table 3 UVB-induced minimal erythema dose, time of exposure and skin characteristics determined before and after PomX, PomJ and placebo intervention.

From: Pomegranate Juice and Extract Consumption Increases the Resistance to UVB-induced Erythema and Changes the Skin Microbiome in Healthy Women: a Randomized Controlled Trial

 

Pom Juice (n = 24)

Pom extract (n = 25)

Placebo (n = 25)

Compliance F (%)

96.3 ± 5.1

97.5 ± 3.9

98.9 ± 2.1

MED BL (mJ/cm2)

383.6 ± 95.8

396.8 ± 83.6

384.2 ± 105.6

MED F (mJ/cm2)

418.3 ± 113.1*

429.6 ± 81.8*

367.2 ± 90.2

Time BL (sec)

175.5 ± 42.9

193.7 ± 46.7

185.6 ± 52.5

Time F (sec)

199.1 ± 58.6

203.6 ± 49.0

177.2 ± 43.6

Melanin index BL (RU)

264.5 ± 212.6

242.7 ± 91.1

202.2 ± 75.4

Melanin index F (RU)

195.0 ± 63.9

219.6 ± 61.0

198.9 ± 67.4

Sebum BL (µg/cm2)

17.0 ± 19.7

14.8 ± 17.5

22.1 ± 36.8

Sebum F (µg/cm2)

15.3 ± 24.4

15.2 ± 18.2

26.9 ± 37.7

Hydration BL (RU)

41.8 ± 14.4

36.4 ± 12.6

41.9 ± 14.5

Hydration F (RU)

38.7 ± 9.8

41.4 ± 11.4

40.9 ± 10.8

  1. Data are mean ± SD, n = 24–25. BL = baseline, F = final, RU = relative unit. ANCOVA model was used to compare outcomes adjusted for baseline value. *p < 0.05. Minimal erythema dose (MED); baseline BL; final (F).